SCHEMBL4534433

SCHEMBL4534433

CON(C)N(C(=O)OC(C)(C)C)[C@H](C)C=O

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CTSK P43235 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL936275 1.00 CTSK (0.31) CTSK
SCHEMBL934743 1.00 CTSK (0.31) CTSK
SCHEMBL17630082 0.84
SCHEMBL4325521 0.80 CTSK (0.31) CTSK
SCHEMBL4325526 0.80 CTSK (0.31) CTSK
SCHEMBL4325602 0.77 HDAC6 (0.32) CTSK
SCHEMBL4325600 0.77 HDAC6 (0.32) CTSK
SCHEMBL4299159 0.77 CTSK (0.34) CTSK
SCHEMBL8274243 0.77 CTSK (0.34) CTSK
SCHEMBL5559416 0.77 CTSK (0.34) CTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2637669-A2 HETEROCYCLIC COMPOUNDS AND USES THEREOF Infinity Pharmaceuticals, Inc. (US) 2013-09-18 EP disclosed
WO-2012064973-A2 HETEROCYCLIC COMPOUNDS AND USES THEREOF INFINITY PHARMACEUTICALS, INC. (US) 2012-05-18 WO disclosed